Vericel Corp (VCEL)
$40.26 -6.18% Close Oct 30, 2026 Live
Vericel stock today
Vericel closed at $40.26 on October 30, 2026, down 6.18% on the day. Over the past year it returned +16.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.06 billion.
$30.00$40.00
NovJan 2026MarMayJulSep
| Period | VCEL | S&P 500 (SPY) |
|---|---|---|
| 1 month | +0.3% | -0.9% |
| 3 months | -15.4% | +2.1% |
| Year to date | +11.8% | +11.7% |
| 1 year | +16.6% | +12.4% |
| 3 years | +17.1% | +88.5% |
| 5 years | -12.5% | +76.0% |
Key statistics
- Market value
- $2.06B
- P/E (trailing)
- 83.9
- Forward P/E
- 59.2
- Price / sales
- 6.7
- 52-week range
- $29.34 to $48.31
- Next report
- Nov 5, 2026
About Vericel
Vericel develops and manufactures regenerative medicine and cellular therapy products.
Sector: Health Care
More on Vericel
- Financials: revenue, earnings and segmentsRevenue +16% in the year to Dec 2025
- Valuation: P/E history and peersP/E 83.9
- Returns: what $1,000 became$1,000 ten years ago is $17,132 today
No forecast, no recommendation. This page describes Vericel Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.